Arkolith/Insider Trading/LCTX/Form 4

Jayasuriya Anula

DirectorLineage Cell Therapeutics, Inc. (LCTX) · full profile →Form 4 · filed Jan 2, 2024
Net Buying
Open-Market Buys
$11K
Open-Market Sells
$0
Net Open-Market Flow
$11K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 29, 2023Buy(P)10K$1.09$11K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-000154) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML